Active Ingredient: EXENATIDE SYNTHETIC
Proprietary Name: BYDUREON
Dosage Form; Route of Administration: FOR SUSPENSION, EXTENDED RELEASE; SUBCUTANEOUS
Strength: 2MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022200
Product Number: 001
Approval Date: Jan 27, 2012
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Discontinued
Patent and Exclusivity Information
